During the past decade, Children's Hospital Augsburg Klinikum conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Children's Hospital Augsburg Klinikum" are "INI1-negative Tumors" (2 trials), "Malignant Rhabdoid Tumor of Ovary" (2 trials), "Synovial Sarcoma" (2 trials), "Any Solid Tumor With an EZH2 GOF Mutation" (1 trials) and "Atypical Teratoid Rhabdoid Tumors (ATRT)" (1 trials). Many other conditions were trialed in "Children's Hospital Augsburg Klinikum" in a lesser frequency.

Most popular intervention types in "Children's Hospital Augsburg Klinikum" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Tazemetostat" (2 trials). Other intervention names were less common.

The vast majority of trials in "Children's Hospital Augsburg Klinikum" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Children's Hospital Augsburg Klinikum". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Children's Hospital Augsburg Klinikum, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Children's Hospital Augsburg Klinikum, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".